Garetosmab
Garetosmab (REGN 2477) is A whole-human IgG4 monoclonal antibody that selectively inhibits activin A and acts on COVID-19 44. Garetosmab has potential anti-cancer activity and can be used to study ossifying fibrous dysplasia (FOP) and cancer.
Product Specifications
CAS Number
2097125-54-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
TGF-beta/Smad
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
P4207-30-HRP 200 µL
PISD, ID (Phosphatidylserine Decarboxylase Proenzyme, Phosphatidylserine Decarboxylase alpha Chain, Phosphatidylserine Decarboxylase beta Chain) (Azide free) (HRP) discontinued
Sign In for Pricing
View Details GTR10450622 96 Well
Mouse Charged multivesicular body protein 3 (VPS24) ELISA kit
Sign In for Pricing
View Details 
125183-ML490 100 µL
COL25A1 (Collagen alpha-1 (XXV) Chain, Alzheimer Disease Amyloid-associated Protein, AMY, CLAC-P, CLAC, CLACP) (MaxLight 490)
Sign In for Pricing
View Details sc-470877B 200 mg
5-Aza-2'-deoxy Cytidine 5'-Monophosphate Triethylamine Salt
Sign In for Pricing
View Details